Furthermore, ClinASO generated a potent ASO targeting <i>ACSL4</i> genes implicated in metabolic dysfunction-associated liver disease (MASLD). The gene discussed is ACSL4; the disease is metabolic dysfunction-associated steatotic liver disease.